TipRanks
Advertisement
Advertisement

SNYNF Stock Latest News

Itepekimab COPD Extension Trial Completion: What It Means for Regeneron and Sanofi
Company AnnouncementsItepekimab COPD Extension Trial Completion: What It Means for Regeneron and Sanofi
1d ago
REGN
U.S. weighs allowing most pharma licensing deals with China, Reuters says
PremiumThe Fly
U.S. weighs allowing most pharma licensing deals with China, Reuters says
1d ago
AZN
BMY
Sanofi inaugurates Canadian flu vaccine faclity
PremiumThe Fly
Sanofi inaugurates Canadian flu vaccine faclity
3d ago
SNY
Sanofi Deepens Cheplapharm Tie-Up in Major Mature Medicines Shift
PremiumCompany Announcements
Sanofi Deepens Cheplapharm Tie-Up in Major Mature Medicines Shift
5d ago
Sanofi, Cheplapharm enter strategic partnership
PremiumThe Fly
Sanofi, Cheplapharm enter strategic partnership
5d ago
SNY
Sanofi Updates Share Capital and Voting Rights Structure for August 2026
PremiumCompany AnnouncementsSanofi Updates Share Capital and Voting Rights Structure for August 2026
8d ago
Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside
Premium
Company Announcements
Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside
8d ago
REGN
Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi
Premium
Company Announcements
Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi
8d ago
REGN
Sanofi price target raised to EUR 100 from EUR 95 at HSBC
PremiumThe Fly
Sanofi price target raised to EUR 100 from EUR 95 at HSBC
9d ago
SNY
Sanofi initiated with a Sector Perform at RBC Capital
PremiumThe Fly
Sanofi initiated with a Sector Perform at RBC Capital
11d ago
SNY
Sanofi: Balanced Risk-Reward as Pipeline Setbacks and Dupixent LOE Temper Growth Outlook, With BD/M&A Execution Key to Equity Story
PremiumRatings
Sanofi: Balanced Risk-Reward as Pipeline Setbacks and Dupixent LOE Temper Growth Outlook, With BD/M&A Execution Key to Equity Story
19d ago
SNY
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
PremiumThe Fly
Novavax’s partners approved for Nuvaxovid formulation for vaccination season
22d ago
SNY
TAK
Regeneron and Sanofi Advance IL-33 Strategy With Completed Rhinosinusitis Trial
PremiumCompany AnnouncementsRegeneron and Sanofi Advance IL-33 Strategy With Completed Rhinosinusitis Trial
25d ago
REGN
Sanofi Shuts Down Early Cancer Drug Trial, Trimming One Piece of Its Oncology Pipeline
Premium
Company Announcements
Sanofi Shuts Down Early Cancer Drug Trial, Trimming One Piece of Its Oncology Pipeline
1M ago
SNYNF
Sanofi Updates Share Capital and Voting Rights as of July 31, 2026
Premium
Company Announcements
Sanofi Updates Share Capital and Voting Rights as of July 31, 2026
1M ago
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
PremiumThe Fly
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
1M ago
SNY
Midday Fly By: Intel announces $15B offering, Meta unveils Muse Glimmer
PremiumThe Fly
Midday Fly By: Intel announces $15B offering, Meta unveils Muse Glimmer
1M ago
BA
ACH
Sanofi facing shortages of two drugs for Pompe disease, STAT reports
PremiumThe Fly
Sanofi facing shortages of two drugs for Pompe disease, STAT reports
1M ago
SNY
Sanofi Wins EU Nod to Use MenQuadfi in Infants From Six Weeks
PremiumCompany Announcements
Sanofi Wins EU Nod to Use MenQuadfi in Infants From Six Weeks
2M ago
Regeneron price target raised to $737 from $696 at RBC Capital
PremiumThe FlyRegeneron price target raised to $737 from $696 at RBC Capital
2M ago
SNY
REGN
Sanofi Publishes 2026 Half-Year Financial Report for Investors
Premium
Company Announcements
Sanofi Publishes 2026 Half-Year Financial Report for Investors
2M ago
Morning Movers: Baxter surges following beat and raise report
Premium
The Fly
Morning Movers: Baxter surges following beat and raise report
2M ago
MO
BAX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >